[Mastocytosis, classification, biological diagnosis and therapy].
In mast cell (MC) disorders (mastocytosis), clinical symptoms are caused by the release of chemical mediators from MCs, the pathologic infiltration of neoplastic MCs in tissues, or both. Cutaneous mastocytosis is a benign disease in which MC infiltration is confined to the skin. In pediatric cases cutaneous mastocytosis might regress spontaneously. Systemic mastocytosis (SM) is more frequently diagnosed in adults and is a persistent (clonal) disease of bone marrow-derived myelomastocytic progenitors. The somatic c-kit mutation D816V is found in the majority of such patients. The natural clinical course in SM is variable. Whereas most patients remain at the indolent stage for many years, some have aggressive SM (ASM) at diagnosis. Other patients have an associated clonal hematologic none MC lineage disease (AHNMD). MC leukemia (MCL) is a rare disease variant characterized by circulating MCs and fatal disease progression. Two important diagnostic clues in SM are an increased serum tryptase level and the presence of abnormal mast cells in the bone marrow. The current review provides an overview of mastocytosis and its subvariants, the new classification of these diseases, a practical guide for the biological diagnosis and advances and future directions in therapy of these pathologies.
Arock
M
M
Unité CNRS UMR 8147, Laboratoire d'hématologie cellulaire et moléculaire, Faculté de pharmacie, Paris. arock@pharmacie.univ-paris5.fr
D001856:Bone Marrow Examination; D006801:Humans; D008407:Mast Cells / Q000166:cytology / Q000473:pathology; D008415:Mastocytosis / Q000145:classification* / Q000175:diagnosis / Q000628:therapy